Airway Management During Deep Sedation in Hysteroscopy
The Effect of Two Different Airway Management on Oxygenation During Deep Sedation in Patients Undergoing Hysteroscopy, Based on Oxygen Reserve Index Monitoring
1 other identifier
interventional
400
1 country
1
Brief Summary
Hysteroscopy is used to examine and treat uterine diseases. Because of severe pain due to uterine distention and cervical dilatation, deep sedation usually be provided during this procedure. Respiratory depression and upper airway obstruction are main respiratory complications during deep sedation. Face mask and nasopharyngeal airway are main airway management during deep sedation. Oxygen reserve index is a non-invasive parameter, it reflects the moderate hyperoxia statues. In this study, investigators compare the effect of face mask and nasopharyngeal airway management on oxygenation during deep sedation in participants undergoing hysteroscopy. Investigators also investigate whether oxygen reserve index monitoring reduce the incidence of hypoxemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 27, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFebruary 1, 2023
October 1, 2022
10 months
December 28, 2022
January 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of low oxygen saturation
oxygen saturation less than 95% last for at least 10 seconds
Procedure (from anesthesia induction to anesthesia recovery)
Secondary Outcomes (2)
Total duration of assist ventilation
Procedure (from anesthesia induction to anesthesia recovery)
The lowest oxygen saturation
Procedure (from anesthesia induction to anesthesia recovery)
Study Arms (4)
face mask airway management without oxygen reserve index monitoring
EXPERIMENTALParticipants inhale oxygen through face mask at a flow rate of 5 L/min and will be monitored with oxygen saturation.
face mask airway management with oxygen reserve index monitoring
EXPERIMENTALParticipants inhale oxygen through face mask at a flow rate of 5 L/min and will be monitored with oxygen reserve index.
nasopharyngeal tube airway management without oxygen reserve index monitoring
EXPERIMENTALParticipants inhale oxygen through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min and will be monitored with oxygen saturation.
nasopharyngeal tube airway management with oxygen reserve index monitoring
EXPERIMENTALParticipants inhale oxygen through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min and will be monitored with oxygen reserve index.
Interventions
In participants with face mask ventilation, oxygen inhaled through face mask at a flow rate of 5 L/min.
In participants with nasopharyngeal tube ventilation, oxygen inhaled through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min.
In participants with oxygen saturation monitoring, assist ventilation through face mask will be performed when oxygen saturation drops to 95%, it lasts for another 10 seconds when oxygen saturation restores to 100%.
In participants with oxygen reserve index monitoring, assist ventilation through face mask will be performed when oxygen reserve index drops to 0.1, it lasts for another 10 seconds when oxygen reserve index restores to 0.1.
Eligibility Criteria
You may qualify if:
- Female, 18-60 years old
- Scheduled for hysteroscopy
- Predict operation duration more than 10 minutes
You may not qualify if:
- Participants refuse
- Predict the presence of difficult airway
- Combined with obstructive sleep apnea syndrome
- Combined with upper respiratory tract infection, and/or pulmonary inflammation
- Combined with chronic obstructive pulmonary disease
- Combined with asthma
- Body mass index (BMI) \>30 kg/m2
- Coagulation dysfunction, and/or undergo anticoagulant therapy
- Nasal deformity
- Pregnancy, positive urine pregnancy test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
Study Officials
- STUDY CHAIR
Zheng Guan, MD
First Affiliated Hospital Xi'an Jiaotong University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2022
First Posted
January 27, 2023
Study Start
February 1, 2023
Primary Completion
November 30, 2023
Study Completion
November 30, 2024
Last Updated
February 1, 2023
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share
Investigators have no plan to make individual participant data available to other researchers